XLO
Xilio Therapeutics, Inc.
+0.02 (+0.22%)9.00USD2.6K成交股數52.0M市值–本益比(近四季)0.8股價營收比+131.2%營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 18.7M+538% | 12.6M | 19.1M+743% | 8.1M+243% | 2.9M | – | 2.3M | 2.4M | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 14.6M | 19.8M | 14.3M | 15.3M | 8.3M | 8.8M | 10.8M | 11.2M | 10.4M | 11.1M | 13.2M | 16.1M |
| 銷售管理費用 | 7.6M | 6.9M | 6.7M | 7.1M | 8.5M | 6.5M | 6.3M | 5.8M | 6.1M | 6.3M | 6.9M | 7.4M |
| 營業利益 | −3.5M-75% | −14.1M+4% | −1.9M-87% | −14.4M-2% | −13.9M-21% | −13.6M-21% | −14.8M-27% | −14.7M-37% | −17.5M | −17.4M | −20.1M | −23.5M |
| 營業利益率 | -18.7% | -111.6% | -10.1% | -177.7% | -472.7% | – | -652.3% | -623.8% | – | – | – | – |
| 稅後淨利 | −6.4M-52% | −9.5M-27% | −16.3M+16% | −15.8M+14% | −13.3M-23% | −13.1M-22% | −14.0M-28% | −13.9M-39% | −17.2M | −16.7M | −19.4M | −22.6M |
| 淨利率 | -34.1% | -75.3% | -85.4% | -196.0% | -452.7% | – | -619.5% | -590.8% | – | – | – | – |
| 稀釋 EPS | -0.33-87% | -0.58-96% | -0.11-50% | -2.30+858% | -2.49+302% | -14.16+2221% | -0.22-69% | -0.24-71% | -0.62 | -0.61 | -0.70 | -0.83 |
| 稀釋股數 | – | – | – | – | – | – | – | – | – | – | – | – |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 136M | 150M | 104M | 122M | 89.1M | 55.3M | 61.3M | 74.9M | 34.0M | 59.8M | 75.4M | 93.3M |
| 應收帳款 | – | – | – | – | – | – | – | – | 30.0M | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 154M | 163M | 134M | 134M | 104M | 71.1M | 74.7M | 89.9M | 82.6M | 77.8M | 92.4M | 112M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 82.0M | 90.9M | 142M | 127M | 93.0M | 53.5M | 53.7M | 56.5M | 56.8M | 25.3M | 25.0M | 26.7M |
| 股東權益 | 72.3M | 72.5M | −8.1M | 7.1M | 10.7M | 17.6M | 21.0M | 33.4M | 25.8M | 52.5M | 67.4M | 84.8M |
| 負債比 | 53.2% | 55.6% | 106.1% | 94.7% | 89.7% | 75.2% | 71.9% | 62.8% | 68.8% | 32.6% | 27.0% | 24.0% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −22.3M | – | – | 29.0M-376% | – | – | – | −10.5M | – | – | −25.3M |
| 資本支出 | – | 556K | – | – | 22K | – | – | – | – | – | – | 170K |
| 自由現金流 | – | −22.9M | – | – | 29.0M | – | – | – | – | – | – | −25.4M |
| 折舊攤銷 | – | 344K | – | – | 497K | – | – | – | 443K | – | – | 499K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -181.0% | – | – | 988.3% | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 43.8M | +589.9% | −35.0M | -80.1% | -4.19 | −5.5M |
| FY2024 | 6.3M | – | −58.2M | -918.0% | -15.24 | −18.4M |
| FY2023 | – | – | −76.4M | –% | -2.78 | −69.1M |
| FY2022 | – | – | −88.2M | –% | -3.22 | −77.6M |
| FY2021 | – | – | −75.8M | –% | -13.52 | −81.9M |
| FY2020 | – | – | −55.2M | –% | -105.42 | −38.3M |